GEODE CAPITAL MANAGEMENT, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 80 filers reported holding XENON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,911,081
-11.2%
55,945
+0.1%
0.00%
Q2 2023$2,152,727
+7.9%
55,915
+0.3%
0.00%
Q1 2023$1,994,397
+91428.1%
55,725
+0.8%
0.00%
Q4 2022$2,179
-99.9%
55,285
-10.6%
0.00%
Q3 2022$2,231,000
+61.2%
61,823
+35.8%
0.00%
Q2 2022$1,384,000
+60.6%
45,516
+61.4%
0.00%
Q1 2022$862,000
-2.0%
28,1980.0%0.00%
Q4 2021$880,000
+166.7%
28,198
+30.2%
0.00%
Q3 2021$330,000
-18.1%
21,6500.0%0.00%
Q2 2021$403,000
+17.2%
21,650
+12.5%
0.00%
Q1 2021$344,000
+16.6%
19,2420.0%0.00%
Q4 2020$295,000
+38.5%
19,2420.0%0.00%
Q3 2020$213,000
-11.6%
19,2420.0%0.00%
Q2 2020$241,000
+10.6%
19,2420.0%0.00%
Q1 2020$218,000
-56.7%
19,242
-50.0%
0.00%
Q4 2019$504,000
+191.3%
38,484
+100.0%
0.00%
Q3 2019$173,000
-8.5%
19,2420.0%0.00%
Q2 2019$189,000
+32.2%
19,242
+36.6%
0.00%
Q1 2019$143,000
-18.8%
14,084
-50.0%
0.00%
Q4 2018$176,000
+329.3%
28,168
+171.2%
0.00%
Q1 2017$41,000
-46.8%
10,386
+3.7%
0.00%
Q4 2016$77,00010,0200.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 850,000$15,215,0003.58%
ACUTA CAPITAL PARTNERS, LLC 412,500$7,384,0002.66%
BVF INC/IL 3,481,778$62,324,0002.34%
Soleus Capital Management, L.P. 708,117$12,675,0002.28%
COMMODORE CAPITAL LP 301,392$5,395,0002.15%
DAFNA Capital Management LLC 406,535$7,277,0001.73%
Parkman Healthcare Partners LLC 374,395$6,702,0001.56%
Avoro Capital Advisors LLC 3,650,000$65,335,0001.13%
KNOTT DAVID M 144,101$2,579,0001.10%
Orbimed Advisors 2,497,917$44,713,0000.42%
View complete list of XENON PHARMACEUTICALS INC shareholders